Item 1A. RISK FACTORS
2K characters. Original on sec.gov · Markdown
Item 1A. RISK FACTORS
There are no material changes to the risk factors disclosed in Part I, Item 1A of our 2025 Annual Report.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table shows information with respect to purchases of our common stock made during the three months ended March 31, 2026 by us or any of our “affiliated purchasers” as defined in Rule 10b-18(a)(3) under the Exchange Act:
| Period | Total number of shares purchased (1) | Average price paid per share (1) | Total number of shares purchased as part of publicly announced plans or programs (1) | Approximate dollar value of shares that may yet be purchased under the plans or programs (1) | ||||||||||||||||||||||
| January 1 - 31, 2026 | — | $ | — | — | $ | 1,000,000,000 | ||||||||||||||||||||
| February 1 - 28, 2026 | 261,636 | $ | 245.11 | 261,636 | 935,900,000 | |||||||||||||||||||||
| March 1 - 31, 2026 | 960,383 | $ | 243.15 | 960,383 | 702,350,000 | |||||||||||||||||||||
| Total | 1,222,019 | $ | 243.57 | 1,222,019 | 702,350,000 |
(1)In February 2026, the Company’s Board of Directors authorized a new share repurchase program for the purchase of up to $1.0 billion of the Company’s common stock in open-market transactions, block transactions, through derivative transactions, privately negotiated transactions, or otherwise, including pursuant to any trading plan entered into by the Company under Rule 10b5-1 of the Exchange Act. This share repurchase program has no expiration date and it may be suspended or terminated at any time.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION